טוען...
M57. Gastrointestinal Disease Impact on Antipsychotic Induced Weight Gain in Schizophrenia: Analysis of Randomized Controlled Trials
Background: Although atypical antipsychotics have been effective at treating psychotic symptoms, secondary effects including weight gain contribute to the development and exacerbation of chronic disease leading to poor outcomes and attenuated lifespan in schizophrenia. The aim of this study was to e...
שמור ב:
הוצא לאור ב: | Schizophr Bull |
---|---|
Main Authors: | , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Oxford University Press
2017
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475815/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx022.054 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|